These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32087035)

  • 1. Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab.
    Halling AS; Zachariae C; Thyssen JP
    Contact Dermatitis; 2020 Jul; 83(1):37-38. PubMed ID: 32087035
    [No Abstract]   [Full Text] [Related]  

  • 2. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema.
    Crepy MN; Nosbaum A; Bensefa-Colas L
    Contact Dermatitis; 2019 Aug; 81(2):145-147. PubMed ID: 30851059
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute and recurrent vesicular hand dermatitis.
    Veien NK
    Dermatol Clin; 2009 Jul; 27(3):337-53, vii. PubMed ID: 19580928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab successfully treated refractory bullous pemphigoid with early clinical manifestations imitating atopic dermatitis: A case letter.
    Zhang Y; Zhang J; Chen J; Lin M; Gong T; Cheng B; Ji C
    Australas J Dermatol; 2021 Nov; 62(4):525-527. PubMed ID: 34448201
    [No Abstract]   [Full Text] [Related]  

  • 5. Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab.
    Loman L; Diercks GFH; Schuttelaar MLA
    Contact Dermatitis; 2021 Feb; 84(2):124-127. PubMed ID: 32864776
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of refractory hand eczema by dupilumab: A case report.
    Dong H; Chen W; Liang B; Li H
    Int J Dermatol; 2024 Jul; 63(7):972-974. PubMed ID: 38402547
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of dupilumab on chronic lymphedema associated hand dermatitis.
    Bouderbala Y; Quere I; Guillemard S; Dereure O; Raison-Peyron N
    Contact Dermatitis; 2024 Nov; 91(5):448-450. PubMed ID: 39031034
    [No Abstract]   [Full Text] [Related]  

  • 8. Hand dermatitis/eczema: current management strategy.
    Sehgal VN; Srivastava G; Aggarwal AK; Sharma AD
    J Dermatol; 2010 Jul; 37(7):593-610. PubMed ID: 20629825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
    Hendricks AJ; Yosipovitch G; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of bullous pemphigoid with dupilumab: a case and brief review of the literature.
    Saleh M; Reedy M; Torok H; Weaver J
    Dermatol Online J; 2021 Apr; 27(4):. PubMed ID: 33999579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab for bullous pemphigoid with intractable pruritus.
    Seidman JS; Eichenfield DZ; Orme CM
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of refractory atypical bullous pemphigoid with generalized eczema and intense pruritus with dupilumab.
    Li W; Cai S; Man X
    Dermatol Ther; 2022 Feb; 35(2):e15243. PubMed ID: 34854196
    [No Abstract]   [Full Text] [Related]  

  • 13. Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid.
    Seyed Jafari SM; Feldmeyer L; Bossart S; Simon D; Schlapbach C; Borradori L
    Front Immunol; 2020; 11():611549. PubMed ID: 33584689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab for the treatment of nivolumab-induced bullous pemphigoid: a case report and review of the literature.
    Klepper EM; Robinson HN
    Dermatol Online J; 2021 Sep; 27(9):. PubMed ID: 34755978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-laminin γ1 pemphigoid.
    Kalkoff EC; Bramsiepe I; Groth S; Marsch WC; Kreft B
    J Dtsch Dermatol Ges; 2013 Jun; 11(6):555-7. PubMed ID: 23480370
    [No Abstract]   [Full Text] [Related]  

  • 16. Bullous pemphigoid successfully treated with dupilumab.
    Martinez DAES; Periquito AFS; Roa GG; Lupi JP; Treu CM; Lupi O
    An Bras Dermatol; 2024; 99(5):778-780. PubMed ID: 38876965
    [No Abstract]   [Full Text] [Related]  

  • 17. Case report: Dupilumab for the treatment of bullous pemphigoid.
    Wang M; Wang J; Shi B
    Dermatol Ther; 2022 Jul; 35(7):e15541. PubMed ID: 35478478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Translated article] Dupilumab to Treat Chronic Palmoplantar Eczema: A Retrospective Multicenter Cohort Study.
    Magdaleno-Tapial J; Torrijos Aguilar A; González-Delgado V; Hernández-Bel P
    Actas Dermosifiliogr; 2024 Jun; 115(6):T628-T631. PubMed ID: 38653369
    [No Abstract]   [Full Text] [Related]  

  • 19. Dyshidrosiform pemphigoid localized on the hands in a child: a rare occurrence.
    Dayal S; Sahu P; Jain VK
    An Bras Dermatol; 2017; 92(5):714-716. PubMed ID: 29166515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab for the treatment of dyshidrotic eczema in 15 consecutive patients.
    Waldman RA; DeWane ME; Sloan B; Grant-Kels JM; Lu J
    J Am Acad Dermatol; 2020 May; 82(5):1251-1252. PubMed ID: 31926220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.